WHO ICTRP trial
A study on the development and application of a risk management programme for…
ChiCTR2400091451 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400091451 |
|---|---|
| Public title | A study on the development and application of a risk management programme for neurogenic bladder in patients with type II diabetes mellitus |
| Scientific title | A study on the development and application of a risk management programme for neurogenic bladder in patients with type II diabetes mellitus |
| Primary sponsor | Fuyong People's Hospital Bao'an District Shenzhen |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Diabetic neurogenic bladder, DNB |
| Interventions | Control group:Routine management of patients with type 2 diabetes;Experimental group:Management programme for patients at high risk of diabetic neurogenic bladder |
| Registration date | Oct 29, 2024 |
| Target size | Control group:91;Experimental group:91 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: